Company Filing History:
Years Active: 2019-2020
Title: Thomas Sandmann: Innovator in Glioblastoma Treatment
Introduction
Thomas Sandmann is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of medical treatments, particularly in the area of glioblastoma. With a total of 3 patents to his name, Sandmann's work focuses on innovative therapies that aim to improve patient outcomes.
Latest Patents
One of Sandmann's latest patents is titled "Combination therapy for the treatment of glioblastoma." This invention concerns methods of treating a patient diagnosed with glioblastoma by administering a therapy that includes an effective amount of an anti-VEGF antibody and a chemotherapeutic agent. Another significant patent is "Diagnostic methods and compositions for treatment of glioblastoma." This invention provides methods and compositions to detect the expression of one or more biomarkers that help identify and treat patients with glioblastomas who are likely to respond to VEGF antagonist therapy. Additionally, it includes kits and articles of manufacture for use in these methods.
Career Highlights
Throughout his career, Thomas Sandmann has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative approaches to glioblastoma treatment.
Collaborations
Some of his notable coworkers include Carlos Bais and Richard Bourgon. Their collaboration has likely contributed to the advancements in the research and development of glioblastoma therapies.
Conclusion
Thomas Sandmann's contributions to glioblastoma treatment through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches continue to pave the way for advancements in medical therapies.